EverQuote CTO exercises options for 15,025 shares

He paid the exercise prices in cash and retained all shares acquired, with no shares sold or withheld.

Available on EDGAR 11/09/2026 - 06:00 PM EST Accepted by SEC EDGAR 11/09/2026 - 06:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

David Brainard, EverQuote, Inc.’s Chief Technology Officer, exercised options for 15,025 Class A common shares on November 6, 2026. The three option lots covered 6,250 shares at an exercise price of $9.41 per share, 2,525 at $7.10, and 6,250 at $5.54. Brainard paid the exercise prices in cash and retained all shares acquired; no shares were sold or withheld. The exercises were outside a Rule 10b5-1 trading plan.

Insider Trade Summary

15,025 shares exercised/converted

Exercise 6 txns

Insider Brainard David

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) F1, F2	6,250	$0.00	$0.00
Exercise	Stock Option (right to buy) F1, F3	2,525	$0.00	$0.00
Exercise	Stock Option (right to buy) F1, F4	6,250	$0.00	$0.00
Exercise	Class A Common Stock F1	6,250	$0.00	$0.00
Exercise	Class A Common Stock F1	2,525	$0.00	$0.00
Exercise	Class A Common Stock F1	6,250	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 3,750 options (Direct); Class A Common Stock — 165,203 shares (Direct)

Footnotes (4)

1. F1. The reporting person exercised this option outside of a Rule 10b5-1 trading plan and paid the exercise price in cash. The reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise.
2. F2. This option was granted on June 28, 2022. The shares underlying the option vested quarterly over four years beginning on August 20 2022.
3. F3. This option was granted on July 24, 2023. The shares underlying the option vest quarterly over four years beginning on August 20 2023.
4. F4. This option was granted on October 24, 2022. The shares underlying the option vest quarterly over two years beginning on November 20, 2024.

Key Figures

Shares exercised: 6,250 shares Exercise price: $9.41 per share Shares exercised: 2,525 shares +3 more

6 metrics

Shares exercised 6,250 shares Option lot with a $9.41 per-share exercise price; November 6, 2026

Exercise price $9.41 per share Option lot covering 6,250 shares; November 6, 2026

Shares exercised 2,525 shares Option lot with a $7.10 per-share exercise price; November 6, 2026

Exercise price $7.10 per share Option lot covering 2,525 shares; November 6, 2026

Shares exercised 6,250 shares Option lot with a $5.54 per-share exercise price; November 6, 2026

Exercise price $5.54 per share Option lot covering 6,250 shares; November 6, 2026

Key Terms

Rule 10b5-1 trading plan, exercise price, vest quarterly

3 terms

Rule 10b5-1 trading plan regulatory

"outside of a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

exercise price financial

"paid the exercise price in cash"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest quarterly financial

"shares underlying the option vest quarterly over four years"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EVER shares did David Brainard acquire through option exercises?

David Brainard exercised options for 15,025 EverQuote Class A common shares on November 6, 2026, across three option lots: 6,250 shares, 2,525 shares, and 6,250 shares. He retained all shares acquired, and no shares were sold or withheld.

What were David Brainard’s EVER option exercise prices?

The exercise prices were $9.41 per share for 6,250 shares, $7.10 per share for 2,525 shares, and $5.54 per share for 6,250 shares, all exercised on November 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brainard David

(Last) (First) (Middle)

C/O EVERQUOTE, INC.

141 PORTLAND STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EverQuote, Inc. [ EVER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/06/2026		M		6,250(1)	A	$0	156,428	D
Class A Common Stock	11/06/2026		M		2,525(1)	A	$0	158,953	D
Class A Common Stock	11/06/2026		M		6,250(1)	A	$0	165,203	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$9.41	11/06/2026		M			6,250(1)	(2)	06/27/2032	Class A Common Stock	6,250	$0	0	D
Stock Option (right to buy)	$7.1	11/06/2026		M			2,525(1)	(3)	07/23/2033	Class A Common Stock	2,525	$0	2,500	D
Stock Option (right to buy)	$5.54	11/06/2026		M			6,250(1)	(4)	10/23/2032	Class A Common Stock	6,250	$0	1,250	D

Explanation of Responses:

1. The reporting person exercised this option outside of a Rule 10b5-1 trading plan and paid the exercise price in cash. The reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise.

2. This option was granted on June 28, 2022. The shares underlying the option vested quarterly over four years beginning on August 20 2022.

3. This option was granted on July 24, 2023. The shares underlying the option vest quarterly over four years beginning on August 20 2023.

4. This option was granted on October 24, 2022. The shares underlying the option vest quarterly over two years beginning on November 20, 2024.

	/s/ Jon Ayotte, as attorney-in-fact for David Brainard	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)